Insights On Pharmaceutical Logistics
-
Risk Mitigation For Late-Stage Clinical Assets
6/11/2025
Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.
-
Friendshoring: A Strategic Shift In Pharma Supply Chains
4/11/2025
To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models.
-
Optimizing End-To-End Contract Analytical Support For Cell And Gene Therapies
7/11/2024
The development and production of CGTs presents unparalleled complexities. Learn how a partner with robust end-to-end services can help you overcome challenges at every step of the drug lifecycle.
-
Cryogenic Storage Of IV Bags For Cell And Gene Therapies
12/18/2025
Cryogenic storage can compromise packaging integrity for cell and gene therapies. Learn how vacuum decay technology detects micro leaks and ensures product safety under extreme conditions.
-
Building A Purification Toolkit For An Expanding Variety Of mAb Therapeutics
5/29/2025
Explore techniques for optimizing purification toolkits for various monoclonal antibody formats. This session covers resin and buffer selection for efficient downstream process development.
-
Fast-Track Innovation, Address CMC Challenges In Expedited Pathways
1/26/2026
Learn to overcome solubility challenges and utilize flexible development strategies to transition innovative treatments from early-phase trials to commercialization while ensuring patient safety.
-
Top Safety Considerations In Biopharmaceutical Manufacturing
4/16/2025
Understanding top safety concerns, from combustible material handling and chemical exposure to HPAPIs, is the first step toward preventing accidents in biopharmaceutical manufacturing environments.
-
The Importance Of Quality In Raw Material Selection
1/16/2025
Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization.
-
Moving Batch Release Into The Fast Lane
1/21/2026
Complex supply chains and fragmented systems slow batch release, delaying patient access and revenue goals. Learn how automation and centralized data improve compliance and accelerate delivery.
-
The Future Of RNA Manufacturing Starts With Raw Material Innovation
2/11/2026
Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.